Immunohistochemical Study of Human Mitochondrial Ferritin in the Substantia Nigra Following Subarachnoid Hemorrhage.

immunohistochemistry iron mitochondrial ferritin subarachnoid hemorrhage

Journal

Acta histochemica et cytochemica
ISSN: 0044-5991
Titre abrégé: Acta Histochem Cytochem
Pays: Japan
ID NLM: 0147110

Informations de publication

Date de publication:
28 Jun 2024
Historique:
received: 04 01 2024
accepted: 21 03 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: ppublish

Résumé

Mitochondrial ferritin (FtMt) is a novel ferritin that sequesters iron and plays a protective role against oxidative stress. FtMt shares a high homology with H-ferritin but is expressed only in the brain, heart, and testis. In the midbrain, FtMt expression is observed in the substantia nigra. FtMt plays a neuroprotective role in the pathology of neurodegenerative diseases such as Parkinson's disease, where excessive iron induces oxidative stress, causing cell death. Herein, we investigated FtMt immunoreactivity in the brains of patients with subarachnoid hemorrhage (SAH). Double immunofluorescence labeling of tyrosine hydroxylase (TH) and FtMt showed high colocalization in the substantia nigra pars compacta (SNc) in control and SAH cases. However, in SAH cases, FtMt immunoreactivity was observed in some TH-negative neurons. Double immunofluorescence labeling of glial cell markers and FtMt showed no apparent colocalization. The number and ratio of FtMt-positive but TH-negative neurons significantly differed between the control and SAH groups. Prussian blue staining in SAH cases showed positive iron staining over a wide surface range and the substantia nigra. Thus, FtMt may be related to iron dynamics in the substantia nigra following subarachnoid hemorrhage.

Identifiants

pubmed: 38988693
doi: 10.1267/ahc.24-00002
pmc: PMC11231567
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101-108

Informations de copyright

2024 The Japan Society of Histochemistry and Cytochemistry.

Déclaration de conflit d'intérêts

VShogo Takahata is the CEO of Medpreneur, a university-based venture company.

Auteurs

Shogo Takahata (S)

Medical Innovation Research Center, Shiga University of Medical Science, Shiga, Japan.

Tomoko Kato (T)

Medical Innovation Research Center, Shiga University of Medical Science, Shiga, Japan.
National Hospital Organization Tottori Medical Center, Tottori, Japan.

Daijiro Yanagisawa (D)

Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga, Japan.

Haruka Tsubaki (H)

Medical Innovation Research Center, Shiga University of Medical Science, Shiga, Japan.

Zulzikry Hafiz Abu Bakar (Z)

Medical Innovation Research Center, Shiga University of Medical Science, Shiga, Japan.
Systems Biology Ireland, University College Dublin, Belfield, Ireland.

Ken-Ichi Mukaisho (KI)

Education Center for Medicine and Nursing, Shiga University of Medical Science, Shiga, Japan.

Yasushi Itoh (Y)

Department of Pathology, Shiga University of Medical Science, Shiga, Japan.
Central Research Laboratory, Shiga University of Medical Science, Shiga, Japan.

Ikuo Tooyama (I)

Medical Innovation Research Center, Shiga University of Medical Science, Shiga, Japan.

Classifications MeSH